Immunovant, Inc.
NASDAQ:IMVT
25.86 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.926 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.08 | 0.064 | 0.058 | 0.349 | 0.343 | 0.341 | 0.333 | 0.327 | 0.323 | 0.314 | 0.313 | 0.305 | 0.3 | 0.241 | 0 | 0 | 0 | 0.463 | 0 | 0.395 | 0.068 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.08 | 1.436 | -0.058 | -0.349 | -0.343 | -0.341 | -0.333 | -0.327 | -0.323 | -0.314 | -0.313 | -0.305 | -0.3 | -0.241 | 0 | 0 | 0 | 0.463 | 0 | -0.395 | -0.068 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.957 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 97.272 | 75.473 | 66.056 | 48.338 | 47.959 | 50.575 | 51.837 | 42.252 | 37.739 | 28.429 | 31.986 | 29.756 | 21.361 | 18.705 | 18.615 | 21.091 | 11.976 | 16.922 | 14.168 | 4.953 | 10.331 | 18.476 | 7.97 | 7.683 | 5.745 | 4.335 |
| General & Administrative Expenses
| 18.471 | 18.808 | 14.823 | 13.215 | 13.841 | 15.402 | 12.422 | 11.775 | 11.875 | 11.946 | 15.241 | 11.515 | 16.289 | 11.181 | 10.302 | 10.549 | 8.998 | 9.664 | 6.315 | 6.088 | 4.163 | 1.585 | 0.963 | 1.201 | 0.495 | 0.033 |
| Selling & Marketing Expenses
| 0 | -0.08 | -0.064 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 18.471 | 18.728 | 14.759 | 13.215 | 13.841 | 15.402 | 12.422 | 11.775 | 11.875 | 11.946 | 15.241 | 11.515 | 16.289 | 11.181 | 10.302 | 10.549 | 8.998 | 9.664 | 6.315 | 6.088 | 4.163 | 1.585 | 0.963 | 1.201 | 0.495 | 0.033 |
| Other Expenses
| 0 | 0.028 | -2.587 | 1.094 | 0.02 | 0.464 | 0.356 | -1.757 | 0.793 | 0.354 | 0.044 | -0.114 | -0.084 | -0.626 | 0.68 | -0.503 | 0.225 | -0.074 | -0.127 | 0.221 | 0.42 | 0.092 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 115.743 | 94.201 | 80.815 | 61.553 | 61.8 | 65.977 | 64.259 | 54.027 | 49.614 | 40.375 | 47.227 | 41.271 | 37.65 | 29.886 | 28.917 | 31.64 | 20.974 | 26.586 | 20.483 | 11.041 | 0.42 | 0.092 | 0 | 8.841 | 6.346 | 4.368 |
| Operating Income
| -115.743 | -94.281 | -80.879 | -51.526 | -58.208 | -73.948 | -64.313 | -44.027 | -49.614 | -40.375 | -47.266 | -41.385 | -37.65 | -29.886 | -28.917 | -31.64 | -20.974 | -26.586 | -20.483 | -11.041 | -0.42 | -0.092 | -0 | -8.884 | -6.24 | -4.368 |
| Operating Income Ratio
| 0 | 0 | -53.919 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 6.702 | 7.208 | 5.792 | 10.027 | 3.592 | 4.529 | 13.836 | -8.813 | 1.947 | 0.354 | 0.044 | -0.114 | -0.084 | -0.626 | 0.68 | -0.503 | 0.225 | -0.074 | -0.127 | -0.155 | 0.683 | 0.342 | 0 | 0.043 | -0.106 | -0 |
| Income Before Tax
| -109.041 | -87.073 | -75.087 | -51.526 | -58.208 | -73.948 | -60.423 | -62.84 | -47.667 | -40.021 | -47.183 | -41.385 | -37.734 | -30.512 | -28.237 | -32.143 | -20.749 | -26.66 | -20.61 | -11.196 | 0.263 | 0.249 | -0 | -8.841 | -6.346 | -4.368 |
| Income Before Tax Ratio
| 0 | 0 | -50.058 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.078 | 0.077 | 0.232 | -0.108 | 0.454 | -0.011 | -0.992 | 0.387 | 0.261 | 0.352 | -0.012 | -0.28 | -0.031 | -0.041 | -0.079 | -0.367 | 0.04 | 0.048 | -0.059 | 0.1 | 0.138 | 0.066 | 0.007 | 0.008 | 0.004 | -0 |
| Net Income
| -109.119 | -87.15 | -75.319 | -51.418 | -58.662 | -73.937 | -59.431 | -63.227 | -47.928 | -40.373 | -47.171 | -41.385 | -37.703 | -30.471 | -28.158 | -31.776 | -20.789 | -26.708 | -20.551 | -11.296 | 0.125 | 0.183 | -0 | -8.849 | -6.35 | -4.368 |
| Net Income Ratio
| 0 | 0 | -50.213 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.198 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.74 | -0.6 | -0.52 | -0.36 | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 | -0.29 | -0.32 | -0.21 | -0.32 | -0.29 | -0.28 | 0.044 | 0.016 | 0 | -0.24 | -0.36 | -0.44 |
| EPS Diluted
| -0.74 | -0.6 | -0.52 | -0.36 | -0.45 | -0.57 | -0.46 | -0.49 | -0.41 | -0.35 | -0.41 | -0.36 | -0.35 | -0.31 | -0.29 | -0.32 | -0.21 | -0.32 | -0.29 | -0.28 | 0.009 | 0.064 | -0 | -0.24 | -0.36 | -0.44 |
| EBITDA
| -115.654 | -94.201 | -80.815 | -61.495 | -61.744 | -65.924 | -64.205 | -53.978 | -49.568 | -40.331 | -47.188 | -41.238 | -37.429 | -29.86 | -28.28 | -31.621 | -20.96 | -26.576 | -20.604 | -10.82 | -0.42 | -0.092 | -0 | -8.883 | 0 | 0 |
| EBITDA Ratio
| 0 | 0 | -53.877 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -22.255 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |